S. Con. Res. 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014
H. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 2015 through 2033
H. J. Res. 59 -- Continuing Appropriations Resolution, 2014
In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs
Implementation of the new health care reform law - PL 111-148, specifically with regard to those provisions impacting Medicare/Medicaid prescription drug coverage, the essential benefit pkg., and other matters.
Pharmaceutical track and trace legislation or as packaged with/tied to pharmaceutical compounding legislation: HR. 1919 - Safeguarding America's Pharmaceutical Act of 2013, HR 3204 - Drug Quality and Security Act, HR 2186 VALID Compounding Act, and S. 959 Pharmaceutical Compounding Quality and Accountability Act
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Administration for Children & Families (ACF)
Affiliated organizations: Takeda Pharmaceutical Company Ltd.
Related Foreign Entities:
Takeda Pharmaceutical Company Ltd. (Chuo-ku, Tokyo 103-8668, JPN); contribution to lobbying: $0; ownership 100%
Bills mentioned
S.CON.RES.8: An original concurrent resolution setting forth the congressional budget...
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Q1 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...